Literature DB >> 11575301

A long-term survivor with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

I Kobayashi, N Kawamura, M Okano.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11575301     DOI： 10.1056/NEJM200109273451314

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Medium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy.

Authors:  Andrea Taddio; Elena Faleschini; Erica Valencic; Marilena Granzotto; Alberto Tommasini; Loredana Lepore; Marino Andolina; Egidio Barbi; Alessandro Ventura
Journal:  Eur J Pediatr       Date:  2007-01-05       Impact factor: 3.183

2.  Low-dose cyclosporine A in a patient with X-linked immune dysregulation, polyendocrinopathy and enteropathy.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Masanobu Kudo; Kazuhiko Sugimoto; Ichiro Kobayashi; Etsuro Ito
Journal:  Eur J Pediatr       Date:  2005-08-10       Impact factor: 3.183

Review 3.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 4.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

Review 5.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

Review 6.  IPEX as a result of mutations in FOXP3.

Authors:  Hans J J van der Vliet; Edward E Nieuwenhuis
Journal:  Clin Dev Immunol       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.